UM

Browse/Search Results:  1-10 of 16 Help

Selected(0)Clear Items/Page:    Sort:
Anticancer Effects of Ginsenoside Rh2: A Systematic Review Journal article
He, Xin Ling, Xu, Xiao Huang, Shi, Jia Jie, Huang, Mingqing, Wang, Yitao, Chen, Xiuping, Lu, Jin Jian. Anticancer Effects of Ginsenoside Rh2: A Systematic Review[J]. Current Molecular Pharmacology, 2022, 15(1), 179-189.
Authors:  He, Xin Ling;  Xu, Xiao Huang;  Shi, Jia Jie;  Huang, Mingqing;  Wang, Yitao; et al.
Favorite | TC[WOS]:7 TC[Scopus]:7  IF:2.4/2.8 | Submit date:2022/02/21
Cancer  Cytotoxicity  Ginseng  Ginsenoside Rh2  Mechanism  Natural Compound  
Functional characterization of three mouse formyl peptide receptors Journal article
He H.-Q., Liao D., Wang Z.-G., Wang Z.-L., Zhou H.-C., Wang M.-W., Ye R.D.. Functional characterization of three mouse formyl peptide receptors[J]. Molecular Pharmacology, 2013, 83(2), 389-398.
Authors:  He H.-Q.;  Liao D.;  Wang Z.-G.;  Wang Z.-L.;  Zhou H.-C.; et al.
Favorite | TC[WOS]:59 TC[Scopus]:57 | Submit date:2018/11/07
Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition Journal article
Kirpotina L.N., Khlebnikov A.I., Schepetkin I.A., Ye R.D., Rabiet M.-J., Jutila M.A., Quinn M.T.. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition[J]. Molecular Pharmacology, 2010, 77(2), 159-170.
Authors:  Kirpotina L.N.;  Khlebnikov A.I.;  Schepetkin I.A.;  Ye R.D.;  Rabiet M.-J.; et al.
Favorite | TC[WOS]:45 TC[Scopus]:46 | Submit date:2018/11/07
ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin Journal article
Park S.-Y., Leung C.-H., Cheng Y.-C.. ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin[J]. Molecular Pharmacology, 2008, 73(6), 1829-1837.
Authors:  Park S.-Y.;  Leung C.-H.;  Cheng Y.-C.
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date:2018/11/06
The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine Journal article
Lam W., Leung C.-H., Bussom S., Cheng Y.-C.. The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine[J]. Molecular Pharmacology, 2007, 72(3), 536-544.
Authors:  Lam W.;  Leung C.-H.;  Bussom S.;  Cheng Y.-C.
Favorite | TC[WOS]:12 TC[Scopus]:11 | Submit date:2018/11/06
Eriocalyxin B inhibits nuclear factor-κB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner Journal article
Leung C.-H., Grill S.P., Lam W., Gao W., Sun H.-D., Cheng Y.-C.. Eriocalyxin B inhibits nuclear factor-κB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner[J]. Molecular Pharmacology, 2006, 70(6), 1946-1955.
Authors:  Leung C.-H.;  Grill S.P.;  Lam W.;  Gao W.;  Sun H.-D.; et al.
Favorite | TC[WOS]:64 TC[Scopus]:71 | Submit date:2018/11/06
Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and β-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and β-D-arabinofuranosylcytosine) Journal article
Lam W., Park S.-Y., Leung C.-H., Cheng Y.-C.. Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and β-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and β-D-arabinofuranosylcytosine)[J]. Molecular Pharmacology, 2006, 69(5), 1607-1614.
Authors:  Lam W.;  Park S.-Y.;  Leung C.-H.;  Cheng Y.-C.
Favorite | TC[WOS]:21 TC[Scopus]:24 | Submit date:2018/11/06
Stereospecific induction of nuclear factor-κB activation by isochamaejasmin Journal article
Tian Q., Li J., Xie X., Sun M., Sang H., Zhou C., An T., Hu L., Ye R.D., Wang M.-W.. Stereospecific induction of nuclear factor-κB activation by isochamaejasmin[J]. Molecular Pharmacology, 2005, 68(6), 1534-1542.
Authors:  Tian Q.;  Li J.;  Xie X.;  Sun M.;  Sang H.; et al.
Favorite | TC[WOS]:21 TC[Scopus]:22 | Submit date:2018/11/07
Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens Journal article
Leung C.-H., Grill S.P., Lam W., Han Q.-B., Sun H.-D., Cheng Y.-C.. Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens[J]. Molecular Pharmacology, 2005, 68(2), 286-297.
Authors:  Leung C.-H.;  Grill S.P.;  Lam W.;  Han Q.-B.;  Sun H.-D.; et al.
Favorite | TC[WOS]:122 TC[Scopus]:130 | Submit date:2018/11/06
Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake Journal article
Lam W., Chen C., Ruan S., Leung C.-H., Cheng Y.-C.. Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake[J]. Molecular Pharmacology, 2005, 67(2), 408-416.
Authors:  Lam W.;  Chen C.;  Ruan S.;  Leung C.-H.;  Cheng Y.-C.
Favorite | TC[WOS]:20 TC[Scopus]:21 | Submit date:2018/11/06